A survey has discovered that 54% of Ukrainians firmly reject the idea of the entire Donbas region being handed over to Russia ...

Genetic and clinical data suggest dietary factors may influence autism risk via immune pathways, highlighting the need for ...

On the contrary, part of the population believes holding elections after a ceasefire will be a necessary step as 35% ...

If your feelings about turbulence are more “this plane is going down!” than “woo, it’s like a rollercoaster,” you might want ...

The ReproSci project retrospectively analyzed the reproducibility of 1006 claims from 400 papers published between 1959 and 2011 in the field of Drosophila immunity. This project attempts to provide a ...

69% of Ukrainians living in Ukraine do not believe that the war waged by the aggressor country Russia will be stopped through ...

Generative AI vendors claim their software ‘learns’ from what it’s fed. Stanford researchers suggest training data gets ...

Santa Monica households will be invited to participate in NHANES, offering free health screenings while contributing to ...

ImmunityBio stock jumps after strong trial updates in bladder cancer and lymphoma, with enrollment ahead of schedule and FDA ...

A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for ...

S&P 500 high P/E doesn’t reliably forecast weak returns—learn why popular charts mislead and how rates, trade, and ...

ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...